about
Guillain–Barré syndrome in Colombia: where do we stand now?Frequently asked questions on seven rare adverse events following immunization."Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse eventsThe first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus.Influenza vaccines: from surveillance through production to protection.Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign.[Guillain-Barré syndrome after exposure to influenza].The neuropsychiatric aspects of influenza/swine flu: A selective review.Attitudes toward and factors affecting influenza vaccination among physicians and nurses of a tertiary-care hospital in the Central Anatolia region of Turkey.Use of simple clinical and laboratory predictors to differentiate influenza from dengue and other febrile illnesses in the emergency room.Guillain-Barre syndrome: Demographics, clinical profile & seasonal variation in a tertiary care centre of central India.Autoimmune diseases, bipolar disorder, and non-affective psychosisNovel anti-idiotype antibody therapy for lipooligosaccharide-induced experimental autoimmune neuritis: use relevant to Guillain-Barré syndrome.Guillain-Barré syndrome incidence in a large United States cohort (2000-2009).In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases.PCR based bronchoscopic detection of common respiratory pathogens in chronic cough: a case control study.Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.Infection and autoimmune disease.Recent developments and future directions in Guillain-Barré syndrome.European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN.Infectious and noninfectious triggers in Guillain-Barré syndrome.Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment.Tumor necrosis factor-α in Guillain-Barré syndrome, friend or foe?The Hidden Burden of Influenza: A Review of the Extra-Pulmonary Complications of Influenza Infection.Impact of HIV on the severity of influenza.Disturbance of Plasma Lipid Metabolic Profile in Guillain-Barre Syndrome.The Spectrum and Burden of Influenza-Associated Neurological Disease in Children: Combined Encephalitis and Influenza Sentinel Site Surveillance From Australia, 2013-2015.Increased Mortality in Seasonal H3N2 Patients Compared with those with Pandemic 2009 H1N1 in Taiwan, 2009-2010.Acute Flaccid paralysis in adults: Our experience.Probiotics as a Potential Alternative for Relieving Peripheral Neuropathies: a Case for Guillain-Barré Syndrome.Increased incidence of Campylobacter jejuni-associated Guillain-Barré syndromes in the Greater Paris area.Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.Guillain-Barré syndrome and glioblastoma.Neurologic Alterations Due to Respiratory Virus Infections
P2860
Q26252481-EC5B0535-0247-4362-B976-23C5A76E6427Q30234430-8277C716-535F-4CC5-B9EE-05C8E6AA567FQ30378494-0E844ACE-6CA5-4F18-AC8B-351B45FB0236Q30381548-29BB0FCA-9E19-4DEB-8A63-6BEAA3D88075Q30385118-F07F3606-BCBF-4016-B536-4EBD44F5EEA2Q30402750-AF4EB767-630C-406E-90FC-A3017937F02BQ30415924-D026A561-2D9D-417C-B1A6-27010AFD22D1Q30425173-F578614F-CFF6-43AD-BB6D-DAA15FEA9C32Q30425964-E0C6FCCF-6EF7-42C0-A124-A980F04F0FF9Q33418844-F60B5E64-EBA1-4160-9C20-52DBB8398EFDQ33882766-2DDAC4EB-ACB5-4A72-807B-D1410ED62BD6Q34179648-0D0D1064-C4FA-4F37-BEF7-E796AF9E47ECQ34451654-9050ECB8-59C9-4CEF-A479-67D24B00ECB7Q34640979-A528B430-9E8A-4EB2-B067-54FC42C4FE59Q34700616-DE543540-B29E-4A16-BF14-93C2E9930199Q36394767-090E1E00-BCEC-49C0-84FE-26CD5C1C0F62Q37207391-A870F8B9-37A5-4A69-889E-95053C28E351Q38027432-52C935DD-133D-44EA-ACCE-030A77CB1CE8Q38070887-E23916D2-2EFE-4726-9C47-A159A737883FQ38077827-9734D12D-70E4-4E75-B703-76ED56EE6DBAQ38125242-5C7D36B8-2704-4C08-9219-ADD1F89A0D4CQ38862736-D6598165-E748-47C4-88F5-B963947EFE1EQ39000208-B21A7CFA-7933-47C7-B93F-3FA19AAD332CQ39458911-12009464-B115-40EB-A101-13C535F9EE03Q39966481-2FC05F7F-CED8-43F3-9A67-5F96B4B9F867Q41419380-CC0BA3FD-9842-467A-AD25-3C367AB0D9CFQ41987697-8BDDC3AF-8613-4651-A661-2AD9C0791EFDQ41989111-8CA904C9-C20C-4D9C-BB7D-FB5DD084B7EAQ42777732-E56F8180-90FF-4AB8-8851-D0EC2072B74CQ43102305-5DB69909-76CE-49DF-84E2-22B2906AC439Q44317794-80D0125E-7601-4E27-A802-6E3F1A81126BQ51849672-5C32AF19-B7B7-41D2-A7B0-B9238EA344FBQ55463649-78BE1D91-62B4-4C8B-82FF-ACEE956EA0EAQ58707396-B1ABAF89-2A23-4E24-85E4-55032F218751
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Guillain-Barré syndrome and influenza virus infection.
@ast
Guillain-Barré syndrome and influenza virus infection.
@en
Guillain-Barré syndrome and influenza virus infection.
@nl
type
label
Guillain-Barré syndrome and influenza virus infection.
@ast
Guillain-Barré syndrome and influenza virus infection.
@en
Guillain-Barré syndrome and influenza virus infection.
@nl
prefLabel
Guillain-Barré syndrome and influenza virus infection.
@ast
Guillain-Barré syndrome and influenza virus infection.
@en
Guillain-Barré syndrome and influenza virus infection.
@nl
P2093
P50
P356
P1476
Guillain-Barré syndrome and influenza virus infection.
@en
P2093
Christiane Caudie
David Orlikowski
Elyanne Gault
Flore Rozenberg
Jean-Claude Raphaël
Jean-Louis Gaillard
Marie-Christine Durand
Pierre Lebon
Tarek Sharshar
Valérie Sivadon-Tardy
P356
10.1086/594124
P407
P577
2009-01-01T00:00:00Z